NCT00883909 2017-07-11
ARI103094-Follow-Up Study for REDUCE Study Subjects
GlaxoSmithKline
Completed
Clinical Trials
4 trialsNCT01337258 2017-05-30
Economic Analyses of the REDUCE Trial
GlaxoSmithKline
Completed
NCT00375765 2017-01-19
Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer
GlaxoSmithKline
Phase 4 Completed
NCT00706966 2014-01-17
MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer
University of California, San Francisco
Phase NA Completed